La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
ClearPoint Neuro Croissance future
Future contrôle des critères 2/6
ClearPoint Neuro devrait augmenter ses bénéfices et ses revenus de 7.4% et de 26.5% par an respectivement, tandis que le BPA devrait croître de croître de 10.7% par an.
Informations clés
7.4%
Taux de croissance des bénéfices
10.7%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 17.4% |
| Taux de croissance des recettes | 26.5% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 08 Aug 2024 |
Mises à jour récentes de la croissance future
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Recent updates
Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?
Aug 16Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%
Jul 11ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 58 | -14 | N/A | N/A | 1 |
| 12/31/2025 | 39 | -17 | -3 | -3 | 3 |
| 12/31/2024 | 31 | -18 | -10 | -10 | 3 |
| 6/30/2024 | 28 | -18 | -10 | -9 | N/A |
| 3/31/2024 | 26 | -21 | -13 | -12 | N/A |
| 12/31/2023 | 24 | -22 | -15 | -14 | N/A |
| 9/30/2023 | 22 | -22 | -17 | -16 | N/A |
| 6/30/2023 | 22 | -21 | -19 | -18 | N/A |
| 3/31/2023 | 21 | -18 | -19 | -18 | N/A |
| 12/31/2022 | 21 | -16 | -17 | -16 | N/A |
| 9/30/2022 | 20 | -16 | -18 | -17 | N/A |
| 6/30/2022 | 19 | -16 | -17 | -16 | N/A |
| 3/31/2022 | 17 | -16 | -15 | -15 | N/A |
| 12/31/2021 | 16 | -14 | -13 | -13 | N/A |
| 9/30/2021 | 16 | -12 | -12 | -12 | N/A |
| 6/30/2021 | 15 | -9 | -10 | -10 | N/A |
| 3/31/2021 | 14 | -7 | -8 | -8 | N/A |
| 12/31/2020 | 13 | -7 | -8 | -8 | N/A |
| 9/30/2020 | 12 | -7 | -6 | -6 | N/A |
| 6/30/2020 | 12 | -6 | -6 | -5 | N/A |
| 3/31/2020 | 12 | -6 | -5 | -5 | N/A |
| 12/31/2019 | 11 | -6 | -3 | -3 | N/A |
| 9/30/2019 | 10 | -5 | -3 | -3 | N/A |
| 6/30/2019 | 9 | -5 | -3 | -3 | N/A |
| 3/31/2019 | 8 | -6 | -3 | -3 | N/A |
| 12/31/2018 | 7 | -6 | -5 | -5 | N/A |
| 9/30/2018 | 7 | -7 | -6 | -6 | N/A |
| 6/30/2018 | 7 | -7 | -7 | -6 | N/A |
| 3/31/2018 | 7 | -7 | N/A | -7 | N/A |
| 12/31/2017 | 7 | -7 | N/A | -6 | N/A |
| 9/30/2017 | 7 | -7 | N/A | -5 | N/A |
| 6/30/2017 | 7 | -8 | N/A | -5 | N/A |
| 3/31/2017 | 6 | -8 | N/A | -6 | N/A |
| 12/31/2016 | 6 | -8 | N/A | -6 | N/A |
| 9/30/2016 | 6 | -8 | N/A | -6 | N/A |
| 6/30/2016 | 5 | -5 | N/A | -6 | N/A |
| 3/31/2016 | 5 | -7 | N/A | -7 | N/A |
| 12/31/2015 | 5 | -8 | N/A | -9 | N/A |
| 9/30/2015 | 4 | -9 | N/A | -9 | N/A |
| 6/30/2015 | 3 | -13 | N/A | -10 | N/A |
| 3/31/2015 | 4 | -11 | N/A | -9 | N/A |
| 12/31/2014 | 4 | -5 | N/A | -7 | N/A |
| 9/30/2014 | 4 | -4 | N/A | -7 | N/A |
| 6/30/2014 | 4 | -4 | N/A | -6 | N/A |
| 3/31/2014 | 3 | -4 | N/A | -7 | N/A |
| 12/31/2013 | 4 | -7 | N/A | -8 | N/A |
| 9/30/2013 | 5 | -4 | N/A | -8 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: CLPT devrait rester non rentable au cours des 3 prochaines années.
Bénéfices vs marché: CLPT devrait rester non rentable au cours des 3 prochaines années.
Croissance élevée des bénéfices: CLPT devrait rester non rentable au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de CLPT ( 26.5% par an) devrait croître plus rapidement que le marché US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de CLPT ( 26.5% par an) devrait croître plus rapidement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de CLPT devrait être élevé dans 3 ans